Advertisement
ASND vs AXSM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a StrongBuy and AXSM is a Hold.
ASND's RSI Oscillator ascends from oversold territory
The RSI Indicator for ASND moved out of oversold territory on September 24, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In 15 of the 18 cases the stock moved higher. This puts the odds of a move higher at 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on ASND as a result. In 74 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for ASND just turned positive on October 09, 2026. Looking at past instances where ASND's MACD turned positive, the stock continued to rise in 38 of 57 cases over the following month. The odds of a continued upward trend are 67%.
Following a +3.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASND advanced for three days, in 185 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for ASND crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
ASND broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ASND entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 12 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. ASND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.940) is normal, around the industry mean (2.988). P/E Ratio (20.367) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (12.970) is also within normal values, averaging (438.009).
AXSM sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for AXSM moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXSM as a result. In 57 of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for AXSM turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 37 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXSM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for AXSM entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
AXSM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. AXSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AXSM's P/B Ratio (98.286) is slightly higher than the industry average of (2.988). P/E Ratio (-41.683) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (13.908) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ASND | AXSM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 89 Overvalued | 94 Overvalued | |
PROFIT vs RISK RATING 1..100 | 59 | 38 | |
SMR RATING 1..100 | 12 | 100 | |
PRICE GROWTH RATING 1..100 | 52 | 64 | |
P/E GROWTH RATING 1..100 | 74 | 16 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ASND's Valuation (89) in the Biotechnology industry is in the same range as AXSM (94) in the Pharmaceuticals Other industry. This means that ASND’s stock grew similarly to AXSM’s over the last 12 months.
AXSM's Profit vs Risk Rating (38) in the Pharmaceuticals Other industry is in the same range as ASND (59) in the Biotechnology industry. This means that AXSM’s stock grew similarly to ASND’s over the last 12 months.
ASND's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for AXSM (100) in the Pharmaceuticals Other industry. This means that ASND’s stock grew significantly faster than AXSM’s over the last 12 months.
ASND's Price Growth Rating (52) in the Biotechnology industry is in the same range as AXSM (64) in the Pharmaceuticals Other industry. This means that ASND’s stock grew similarly to AXSM’s over the last 12 months.
AXSM's P/E Growth Rating (16) in the Pharmaceuticals Other industry is somewhat better than the same rating for ASND (74) in the Biotechnology industry. This means that AXSM’s stock grew somewhat faster than ASND’s over the last 12 months.
| ASND | AXSM | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | 2 days ago 87% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Momentum ODDS (%) | 2 days ago 80% | 3 days ago 81% |
| MACD ODDS (%) | 2 days ago 67% | 2 days ago 74% |
| TrendWeek ODDS (%) | 2 days ago 71% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 76% |
| Advances ODDS (%) | 2 days ago 70% | N/A |
| Declines ODDS (%) | 7 days ago 72% | 4 days ago 77% |
| BollingerBands ODDS (%) | 2 days ago 88% | 2 days ago 79% |
| Aroon ODDS (%) | 2 days ago 81% | 2 days ago 78% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASND’s FA Score shows that 1 FA rating(s) are green while AXSM’s FA Score has 1 green FA rating(s).
- ASND’s FA Score: 1 green, 4 red.
- AXSM’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASND’s TA Score shows that 4 TA indicator(s) are bullish while AXSM’s TA Score has 3 bullish TA indicator(s).
- ASND’s TA Score: 4 bullish, 5 bearish.
- AXSM’s TA Score: 3 bullish, 5 bearish.
Price Growth
ASND (@Biotechnology) experienced а +5.24% price change this week, while AXSM (@Biotechnology) price change was -3.64% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.12%. For the same industry, the average monthly price growth was -17.33%, and the average quarterly price growth was -14.22%.
Reported Earning Dates
ASND is expected to report earnings on Nov 11, 2026.
AXSM is expected to report earnings on Nov 02, 2026.
Industries' Descriptions
@Biotechnology (-0.12% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ASND and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASND has been loosely correlated with ORMP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then ORMP could also see price increases.
| Ticker / NAME | Correlation To ASND | 1D Price Change % | ||
|---|---|---|---|---|
| ASND | 100% | +1.95% | ||
| ORMP - ASND | 37% Loosely correlated | -0.24% | ||
| PTGX - ASND | 36% Loosely correlated | +0.07% | ||
| AMRN - ASND | 35% Loosely correlated | +0.26% | ||
| AXON - ASND | 34% Loosely correlated | +2.54% | ||
| TARS - ASND | 34% Loosely correlated | -0.75% | ||
More | ||||
AXSM and
Correlation & Price change
A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with CYTK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then CYTK could also see price increases.
| Ticker / NAME | Correlation To AXSM | 1D Price Change % | ||
|---|---|---|---|---|
| AXSM | 100% | -2.05% | ||
| CYTK - AXSM | 40% Loosely correlated | -1.70% | ||
| PHVS - AXSM | 40% Loosely correlated | -0.78% | ||
| MIRM - AXSM | 37% Loosely correlated | -1.92% | ||
| RYTM - AXSM | 36% Loosely correlated | -1.75% | ||
| BBIO - AXSM | 36% Loosely correlated | +0.28% | ||
More | ||||